The role of long-range intermolecular interactions in discovery of new drugs

Expert Opinion on Drug Discovery

Volumn 6, Issue 12, 2011, Pages 1263-1270

  Veljkovic, Nevena ^a   Glisic, Sanja ^a   Perovic, Vladimir ^a   Veljkovic, Veljko ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Drug discovery; Long range intermolecular interactions; Molecular descriptors; Virtual screening

Indexed keywords

AMINOGLYCOSIDE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIBIOTIC AGENT; BC 3205; CARBAPENEM DERIVATIVE; CEFTAROLINE; CEPHALOSPORIN DERIVATIVE; FLAVONOID; MACROLIDE; MONOBACTAM DERIVATIVE; NITROFURAN DERIVATIVE; PENICILLIN G; PLEUROMUTILIN; QUINOLINE DERIVATIVE; TETRACYCLINE DERIVATIVE; UNCLASSIFIED DRUG;

BIOLOGY; DRUG EFFICACY; DRUG INTERACTION; DRUG RESEARCH; DRUG SAFETY; HUMAN; MOLECULAR INTERACTION; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW;

EID: 83455201155     PISSN: 17460441     EISSN: 1746045X     Source Type: Journal    
DOI: 10.1517/17460441.2012.638280     Document Type: Review

References (62)

1. DiMasi JA, Hansen RW, Grabowski HG. The price of innovation: new estimates of drug development costs. J Health Econ 2003;22:151-85 (Pubitemid 36279392)
2. Dimasi JA. Risks in new drug development: approval success rates for investigational drugs. Clin Pharmacol Ther 2001;69:297-307
3. McGee P. Modeling success with in silico tools. Drug Discov Devel 2005;8:24-8
4. Brooijmans N, Kuntz ID. Molecular recognition and docking algorithms. Annu Rev Biophys Biomol Struct 2003;32:335-73 (Pubitemid 37056233)
5. Goodsell DS, Morris GM, Olson AJ. Automated docking of flexible ligands: applications of AutoDock. J Mol Recognit 1996;9:1-5 (Pubitemid 126565462)
6. Burkhard P, Taylor P, Walkinshaw MD. An example of a protein ligand found bydatabase mining: description of the docking method and its verification by a 2.3 A X-ray structure of a thrombin-ligand complex. J Mol Biol 1998;277:449-66 (Pubitemid 28174979)
7. Lorber DM, Shoichet BK. Flexible ligand docking using conformational ensembles. Protein Sci 1998;7:938-50 (Pubitemid 28216535)
8. Kramer B, Rarey M, Lengauer T. Evaluation of the FLEXX incremental construction algorithm for protein-ligand docking. Proteins 1999;37:228-41 (Pubitemid 29503004)
9. Taylor JS, Burnett RM. DARWIN: a program for docking flexible molecules. Proteins 2000;41:173-91
10. Ewing TJ, Makino S, Skillman AG, et al. DOCK 4.0: search strategies for automated molecular docking of flexible molecule databases. J Comput Aided Mol Des 2001;15:411-28 (Pubitemid 32452109)
11. Jiang F, Kim SH. "Soft docking": matching of molecular surface cubes. J Mol Biol 1991;219:79-102 (Pubitemid 121003975)
12. Tuffery P, Etchebest C, Hazout S, et al. A new approach to the rapid determination of protein side chain conformations. J Biomol Struct Dyn 1991;8:1267-89
13. Dunbrack RL Jr, Karplus M. Backbone-dependent rotamer library for proteins. Application to side-chain prediction. J Mol Biol 1993;230:543-74 (Pubitemid 23161363)
14. Leach AR. Ligand docking to proteins with discrete side-chain flexibility. J Mol Biol 1994;235:345-56 (Pubitemid 24049519)
15. Leach AR, Lemon AP. Exploring the conformational space of protein side chains using dead-end elimination and the A* algorithm. Proteins 1998;33:227-39 (Pubitemid 28457975)
16. Kallblad P, Dean PM. Efficient conformational sampling of local side-chain flexibility. J Mol Biol 2003;326:1651-65 (Pubitemid 36269099)
17. Morris GM, Huey R, Lindstrom W, et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem 2009;30:2785-91
18. Kern D, Eisenmesser EZ, Wolf-Watz M. Enzyme dynamics during catalysis measured by NMR spectroscopy. Methods Enzymol 2005;394:507-24 (Pubitemid 40460930)
19. Lin JH, Perryman AL, Schames JR, et al. Computational drug design accommodating receptor flexibility: the relaxed complex scheme. J Am Chem Soc 2002;124:5632-3 (Pubitemid 34533490)
20. Lin JH, Perryman AL, Schames JR, et al. The relaxed complex method: accommodating receptor flexibility for drug design with an improved scoring scheme. Biopolymers 2003;68:47-62 (Pubitemid 36098307)
21. Amaro RE, Baron R, McCammon JA. An improved relaxed complex scheme for receptor flexibility in computer-aided drug design. J Comput Aided Mol Des 2008;22:693-705
22. Cheng LS, Amaro RE, Xu D, et al. Ensemble-based virtual screening reveals potential novel antiviral compounds for avian influenza neuraminidase. J Med Chem 2008;51:3878-94 (Pubitemid 351956517)
23. Babakhani A, Talley TT, Taylor P, et al. A virtual screening study of the acetylcholine binding protein using a relaxed-complex approach. Comput Biol Chem 2009;33:160-70
24. Amaro RE, Li WW. Emerging methods for ensemble-based virtual screening. Curr Top Med Chem 2010;10:3-13
25. Durrant JD, Urbaniak MD, Ferguson MA, et al. Computer-aided identification of Trypanosoma brucei uridine diphosphate galactose 4'-epimerase inhibitors: toward the development of novel therapies for African sleeping sickness. J Med Chem 2010;53:5025-32
26. Damm KL, Carlson HA. Exploring experimental sources of multiple protein conformations in structure-based drug design. J Am Chem Soc 2007;129:8225-35 (Pubitemid 47039084)
27. Lerner MG, Bowman AL, Carlson HA. Incorporating dynamics in E. coli dihydrofolate reductase enhances structure-based drug discovery. J Chem Inf Model 2007;47:2358-65 (Pubitemid 350275100)
28. Bowman AL, Nikolovska-Coleska Z, Zhong H, et al. Small molecule inhibitors of the MDM2-p53 interaction discovered by ensemble-based receptor models. J Am Chem Soc 2007;129:12809-14 (Pubitemid 350004494)
29. Lexa KW, Carlson HA. Full protein flexibility is essential for proper hot-spot mapping. J Am Chem Soc 2011;132:200-2
30. Smoluchowski MV. Versuch einer mathematischen Theorie der Koagulationskinetik kolloider Losungen. Phys Z 1916;17:129-68
31. Northrup SH, Erickson HP. Kinetics of protein-protein association explained by Brownian dynamics computer simulation. Proc Natl Acad Sci USA 1992;89:3338-42
32. Wiegel FW, DeLisi C. Evaluation of reaction rate enhancement by reduction in dimensionality. Am J Physiol 1982;243:R475-9 (Pubitemid 13196937)
33. McCloskey MA, Poo MM. Rates of membrane-associated reactions: reduction of dimensionality revisited. J Cell Biol 1986;102:88-96 (Pubitemid 16155556)
34. Peters R. Translocation through the nuclear pore complex: selectivity and speed by reduction-of-dimensionality. Traffic 2005;6:421-7 (Pubitemid 40542768)
35. Brune D, Kim DS. Hydrodynamic steering effects in protein association. Proc Natl Acad Sci USA 1994;91:2930-4 (Pubitemid 24130148)
36. Camacho CJ, Kimura SR, DeLisi C, et al.Kinetics of desolvation- mediated protein-protein binding. Biophys J 2000;78:1094-105 (Pubitemid 30141539)
37. Sines JJ, Allison SA, McCammon JA. Point charge distributions and electrostatic steering in enzyme/substrate encounter: brownian dynamics of modified copper/zinc superoxide dismutases. Biochemistry 1990;29:9403-12 (Pubitemid 20329077)
38. Tan RC, Truong TN, McCammon JA, et al. Acetylcholinesterase: electrostatic steering increases the rate of ligand binding. Biochemistry 1993;32:401-3 (Pubitemid 23034875)
39. Antosiewicz J, Wlodek ST, McCammon JA. Acetylcholinesterase: role of the enzyme's charge distribution in steering charged ligands toward the active site. Biopolymers 1996;39:85-94
40. Wlodek ST, Shen T, McCammon JA. Electrostatic steering of substrate to acetylcholinesterase: analysis of field fluctuations. Biopolymers 2000;53:265-71 (Pubitemid 30082313)
41. Chang C, Shen T, Trylska J, et al. Gated binding of ligands to HIV-1 protease: brownian dynamics simulations in a Coarse-Grained model. Biophys J 2006;90:3880-5 (Pubitemid 43846106)
42. Cheng Y, Suen JK, Zhang D, et al. Finite element analysis of the time-dependent Smoluchowski equation for acetylcholinesterase reaction rate calculations. Biophys J 2007;92:3397-406 (Pubitemid 46698633)
43. Sung JC, Van Wynsberghe AW, Amaro RE, et al. Role of secondary sialic acid binding sites in influenza N1 neuraminidase. J Am Chem Soc 2010;132:2883-5
44. Frohlich H. Long-range coherence and energy storage in biological systems. Int J Quantum Chem 1968;2:641-9.
45. Frohlich H. Long range coherence and the action of enzymes. Nature 1970;228:1093
46. Frohlich H. The extraordinary dielectric properties of biological materials and the action of enzymes. Proc Natl Acad Sci USA 1975;72:4211-15
47. Veljkovic V. A theoretical approach to preselection of carcinogens and chemical carcinogenesis. Gordon & Breach; New York: 1980
48. Veljkovic V, Lalovic D. Theoretical prediction of mutagenicity and carcinogenicity of chemical substances. Cancer Biochem Biophys 1976;1:295-8 (Pubitemid 8015119)
49. Veljkovic V, Slavic I. Simple general-model pseudopotential. Phys Rev Lett 1972;29:105-7
50. Veljkovic V. The dependence of the Fermi energy on the atomic number. Phys Lett 1973;45A:41-2
51. Veljkovic V, Lalovic D. General model pseudopotential for positive ions. Phys Lett 1973;45A:59-60
52. Todeschini R, Consoni V. Molecular descriptors for chemoinformatics. Wiley VCH Verlag; Weinheim: 2009
53. Reddy AS, Pati SP, Kumar PP, et al. Virtual screening and drug discovery - A computational perspective. Curr Protein Pept Sci 2007;8:329-51 (Pubitemid 47317040)
54. Available from: http://chemdb. niaid.nih.gov/
55. Tintori C, Manetti F, Veljkovic N, et al. Novel virtual screening protocol based on the combined use of molecular modeling and electron-ion interaction potential techniques to design HIV-1 integrase inhibitors. Chem Inf Model 2007;47:1536-44 (Pubitemid 47210056)
56. Mugnaini C, Rajamaki S, Tintori C, et al. Toward novel HIV-1 integrase binding inhibitors: molecular modeling, synthesis, and biological studies. Bioorg Med Chem Lett 2007;17:5370-3 (Pubitemid 47393701)
57. Veljkovic V, Veljkovic N, Este JA, et al. Application of the EIIP/ISM bioinformatics concept in development of new drugs. Curr Med Chem 2007;14:441-53
58. Veljkovic V, Mouscadet JF, Veljkovic N, et al. Simple criterion for selection of flavonoid compounds with anti-HIV activity. Bioorg Med Chem Lett 2007;17:1226-32 (Pubitemid 46242193)
59. Wang Z, Bennett EM, Wilson DJ, et al. Rationally designed dual inhibitors of HIV reverse transcriptase and integrase. J Med Chem 2007;50:3416-19 (Pubitemid 47195448)
60. Available from: http://www.ncbi.nlm.nih. gov/pccompound
61. Kumarasamy KK, Toleman MA, Walsh TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010;10:597-602
62. Theuretzbacher U. Future antibiotics scenarios: is the tide starting to turn? Int J Antimicrob Agents 2009;34:15-20